Atopic Dermatitis: Targeting Underlying Inflammatory Pathways with Systemic Therapy THE THRIVE INITIATIVE
Course Evaluation Survey What is your specialty focus?(Required) Dermatology Immunology/allergology Primary care Internal medicine Pharmacy Other Specify:(Required) What is your type of practice?(Required) Community/Private SNF/Nursing Home Academic Hospital HMO/MCO Other Specify:(Required) How many years have you been in practice?(Required) Fewer than 5 5 to 9 10 to 15 More than 15 Please estimate the number of patients with moderate-to-severe atopic dermatitis you provide for weekly:(Required) Fewer than 5 5-10 11-15 16-20 21-25 26 –30 30-50 > 50 Not applicable Were the following learning objectives met? (Please check appropriate rating)(Required)Strongly AgreeAgreeNeutralDisagreeStrongly DisagreeApply up-to-date guidance on the initiation and use of systemic immunosuppressants and immunomodulators in patients with atopic dermatitis during the COVID-19 pandemicAssess the severity of atopic dermatitis and select appropriate treatment options for patients who require intensified therapyReview the mechanism of action, efficacy and safety of systemic treatments for atopic dermatitis in pediatric and adult patientsPlease rate your confidence in ability to diagnose, treat, and manage moderate-to-severe atopic dermatitis on a scale of 1 to 5, where 1 means “Not confident at all” and 5 means “Very Confident.”(Required)Not confident at all12Somewhat Confident34Very Confident5As a result of this course, I will likely make changes to my practice:(Required) YES NO N/A If YES, in which of the following categories? (Please check all that apply) Diagnosis Treatment approach Patient safety Coordination of care Patient communication/ education In particular, as a result of this course, I will be more likely to implement the following changes (Please check all that apply):(Required) I am more likely to assess the mental and social impact of AD when selecting treatment options. I am more likely to identify patients with AD who require intensified therapy. I am more likely to incorporate treatment guidelines and clinical trial data into treatment plans for adult and pediatric patients with moderate-to-severe disease. I am more likely to consider a patient’s risk of severe COVID-19 when initiating systemic therapy. Additionally, I will change: Specify:What barriers may prevent/inhibit changes in practice recommended in this activity? Cost Time Number of Patients Access/availability Patient understanding Compliance Other Specify: Did you view the animations offered in this program?(Required) YES NO If YES, how do you feel the animations impacted your learning? (Please check all that apply) Improved ability to assess the severity of atopic dermatitis and intensify therapy appropriately Improved ability to select treatment options for adult and pediatric patients based on an understanding of the efficacy and safety of systemic treatments Improved ability to apply up-to-date guidance on the initiation and use of systemic immunosuppressants and immunomodulators in patients with AD during the COVID-19 pandemic Will improve recall of lessons learned Will improve dialogue with patients Will improve ability to individualize treatment Please evaluate this activity as a whole. (Please check appropriate rating)(Required)Strongly AgreeAgreeNeutralDisagreeStrongly DisagreeThe learning format was interactive and engaging.The content was pertinent to my professional needs.The activity will ultimately benefit patient care.I would recommend this activity to colleagues.Do you feel a commercial product, device, or services was inappropriately promoted in this educational activity?(Required) YES NO If YES, please comment:(Required)What was the most effective aspect(s) of this learning activity?(Required) Faculty expertise Educational format Visual aids Content Case studies Other: Specify:(Required) Do you have suggestions for improving the session or topics for future activities? New and emerging therapies Diagnostic tools/techniques Patient education/communication Other treatment modalities Coordination of care Other: Specify:(Required) Please evaluate the faculty (Please check appropriate rating)(Required)ExcellentGoodAverageFairPoorDonald Leung, MDPeter Lio, MDThank you. Any additional comments are welcome below.If you have any concerns you would like to discuss, please email us at info@medlearninggroup.com. To better understand the value of this program, MLG may contact you with a follow-up survey. This survey is designed to assess the value of the program and measure any behavior change. We truly appreciate your participation. Consent Yes, Med Learning Group has my permission to fax or email information to me about further programs.